Progress of "Current Alzheimer Research" and future direction

Current Alzheimer Research

Volumn 10, Issue 1, 2013, Pages 1-3

  Lahiri, Debomoy K ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SECRETASE; ALZHEIMER DISEASE VACCINE; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; DAVUNETIDE; DIMEBON; GAMMA SECRETASE; MEMBRANE PROTEIN; NOOTROPIC AGENT; ROSIGLITAZONE; SEMAGACESTAT;

ALZHEIMER DISEASE; ANXIETY; CHELATION; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDITORIAL; EPIGENETICS; HUMAN; LIFESTYLE; MEDICAL LITERATURE; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; OXIDATIVE STRESS; PASSIVE IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PUBLICATION; STRESS; TRANSLATIONAL RESEARCH; MEDICAL RESEARCH;

ALZHEIMER DISEASE; BIOMEDICAL RESEARCH; HUMANS;

EID: 84882370719     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720513804871462     Document Type: Editorial

References (18)

1. National Institute on Aging, National institutes of Health. Alz heimer's Disease Fact Sheet (2012) http://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-fact-sheet
2. Alzheimer's Association. Alzheimer's Facts and Figures (2012) http://www.alz.org/alzheimers_disease_facts_and_figures.asp
3. Alzheimer's Disease International/WHO-dementia-report (2012). http://whqlibdoc.who.int/publications/2012/9789241564458_eng.pdf
4. Lahiri DK. Unraveling nature's secrets, from neurons and memory to brain disorders: exploring the new frontier of Alzheimer's disease. Curr. Alzheimer Res 1(1): 1-3 (2004).
5. Lahiri DK. 'Current Aging Science': An important platform for reporting advances in aging-related research. Curr Aging Sci 3(1): 1-2 (2010).
6. Maudsley S, Chadwick W. Progressive and unconventional phar-macotherapeutic approaches to Alzheimer's disease therapy. Curr Alzheimer Res 9(1): 1-4 (2012).
7. Hartmann D. A brief history of APP secretases, their substrates and their functions. Curr Alzheimer Res 9(2): 138-9 (2012).
8. Zawia NH, Lahiri DK. Epigenetics: a paradigm shift in understanding Alzheimer's disease. Curr Alzheimer Res 9(5): 525-6 (2012).
9. Bennett DA, Launer LJ. Longitudinal epidemiologic clinical-pathologic studies of aging and Alzheimer's disease. Curr Alzheimer Res 9(6): 617-20 (2012).
10. Holtzman DM, Mandelkow E, Selkoe DJ. Alzheimer disease in 2020. Cold Spring Harb Perspect Med 2(11): (2012) pii:a011585. doi:10.1101/cshperspect.a011585.
11. Lahiri DK, Maloney B, Zawia NH. The LEARn model: an epige-netic explanation for idiopathic neurobiological diseases. Mol Psychiatry 14(11): 992-1003 (2009).
12. Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488: 96-9 (2012).
13. Carrillo MC, Bain LJ, Frisoni GB, Weiner MW. Worldwide Alzheimer's disease neuroimaging initiative. Alzheimers Dement 8(4): 337-42 (2012).
14. Lahiri DK. An integrated approach to genome studies. Science 331(6014): 147 (2011).
15. Lahiri DK. Awakening and Beliefs in Trials of Alzheimer's (ABeTA). (2012) http://comments.sciencemag.org/con-tent/10.1126/science.337.6096.790
16. Alzheimer's Association, http://www.alz.org/join_the_cause_21243.asp
17. National Institute on Aging, National institutes of Health. http://www.nia.nih.gov/about/budget/2012/fiscal-year-2013-budget/directors-statement-fiscal-year-2013-budget-request.
18. Alzheimer Research Forum, Alzforum's Top 12 of 2012 http://www.alzforum.org/new/detail.asp?id=3362